K D Bagshawe
-
- Monoclonal and Polyclonal Antibodies Research 21
- Radiopharmaceutical Chemistry and Applications 10
- Reproductive Medicine top 5%
- Biotechnology top 2%
-
- Gestational Trophoblastic Disease Studies 30
- Ectopic Pregnancy Diagnosis and Management 7
- Oncology top 5%
- Peptidase Inhibition and Analysis 6
-
- Glycosylation and Glycoproteins Research 9
-
- Testicular diseases and treatments 9
-
- Neuroblastoma Research and Treatments 9
- Co-authors
- F SearleRichard H. J. BeǵentGordon RustinE.S. NewlandsRG MeltonR.F. SherwoodPari AntoniwSK Sharma
- Partner nations
- United KingdomUnited StatesFinland
In The Last Decade
K D Bagshawe
93 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 104
- Radiology, Nuclear Medicine and Imaging 890
- Reproductive Medicine 216
- Biotechnology 206
- Public Health, Environmental and Occupational Health 600
- Oncology 508
Countries citing papers authored by K D Bagshawe
This map shows the geographic impact of K D Bagshawe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K D Bagshawe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K D Bagshawe more than expected).
Fields of papers citing papers by K D Bagshawe
This network shows the impact of papers produced by K D Bagshawe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K D Bagshawe. The network helps show where K D Bagshawe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K D Bagshawe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - REVIEW | 1994 | 0 |
| 2 | 1994 | 5 | |
| 3 | ANTIBODY-ENZYME CONJUGATES CAN GENERATE CYTOTOXIC DRUGS FROM INACTIVE PRECURSORS AT TUMOR SITES | 1991 | 4 |
| 4 | PHASE I/II STUDY OF CHIMERIC B72.3 ANTIBODY IN RADIOIMMUNOTHERAPY OF COLORECTAL-CARCINOMA | 1990 | 7 |
| 5 | 1990 | 9 | |
| 6 | 1990 | 18 | |
| 7 | 1990 | 38 | |
| 8 | 1989 | 96 | |
| 9 | 1989 | 4 | |
| 10 | 1989 | 50 | |
| 11 | 1988 | 33 | |
| 12 | 1988 | 7 | |
| 13 | 1988 | 15 | |
| 14 | 1988 | 65 | |
| 15 | 1987 | 2 | |
| 16 | 1987 | 4 | |
| 17 | CARBOXYPEPTIDASE G2 CONJUGATES WITH LOCALIZING ANTITUMOR ANTIBODIES - POTENTIAL THERAPEUTIC AGENTS | 1986 | 1 |
| 18 | 1980 | 16 | |
| 19 | 1969 | 27 | |
| 20 | 1966 | 17 |
About K D Bagshawe
K D Bagshawe is a scholar working on Radiology, Nuclear Medicine and Imaging, Public Health, Environmental and Occupational Health and Reproductive Medicine, having authored 96 papers that have together received 2.5k indexed citations. Recurring topics across this work include Gestational Trophoblastic Disease Studies (30 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Glycosylation and Glycoproteins Research (9 papers), Testicular diseases and treatments (9 papers), Neuroblastoma Research and Treatments (9 papers), Ectopic Pregnancy Diagnosis and Management (7 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (890 citations), Reproductive Medicine (216 citations) and Biotechnology (206 citations). K D Bagshawe has collaborated with scholars based in United Kingdom, United States and Finland. Frequent co-authors include F Searle, Richard H. J. Beǵent, Gordon Rustin, E.S. Newlands, RG Melton, R.F. Sherwood, Pari Antoniw, SK Sharma, Springer Cj and A Kardana.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.